“…If we indeed consider type 1 diabetes mellitus, several recent studies on young and normal-weight patients using continuous glucose monitoring (CGM) systems found an unexpected improvement in glycemic control during the lockdown [ 12 , 15 , 16 ]. This can be explained by a more regular lifestyle during quarantine: the rhythm of daily activities slowed down, they were able to eat at more reproducible mealtimes, they were allowed to have a more controlled composition of meals [ 22 ]. Moreover, patients could spend more time on diabetes control, which is known to be a critical aspect of both insulin multi-injections or insulin pump therapy [ 9 , 23 ].…”